Abstract
The use of amantadine has been advocated as treatment for influenza A encephalitis despite limited information regarding cerebrospinal fluid concentrations and the pathogenesis of encephalitis associated with influenza virus infections. We report a 2-year-old child with influenza A encephalitis treated with amantadine who achieved a potentially therapeutic concentration in cerebrospinal fluid. Despite this the child developed significant neurologic impairment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 270-272 |
| Number of pages | 3 |
| Journal | Pediatric Infectious Disease Journal |
| Volume | 23 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2004 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Pediatrics, Perinatology, and Child Health
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Amantadine penetration into cerebrospinal fluid of a child with influenza A encephalitis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver